Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

iShares Nasdaq Biotechnology ETF

+ Add to Watchlist

IBB:US

364.5400 USD 0.9400 0.26%

As of 20:10:00 ET on 05/22/2015.

Snapshot for iShares Nasdaq Biotechnology ETF (IBB)

Open: 363.5300 High - Low: 365.4900 - 362.6700 Primary Exchange: NASDAQ GM
Volume: 883,722 52-Week Range: 236.2500 - 374.9700 Beta vs XNBI: 1.0006

ETF Chart for IBB

No chart data available.
  • IBB:US 364.5400
  • 1D
  • 1M
  • 1Y
363.6000
Interactive IBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IBB

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2001-02-09 Telephone: 1-415-670-2000
Managers: GREG SAVAGE / RENE CASIS
Web Site: www.ishares.com

Fundamentals for IBB

NAV (on 2015-05-22) 364.3400
Assets (M) (on 2015-05-21) 8,925.5234
Shares out (M) 24.60
Market Cap (M) 8,967.68
% Premium 0.05
Average 52-Week % Premium 0.0128
Fund Leveraged N

Dividends for IBB

Dividend Type Omitted
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.12%

Performance for IBB

1-Month +0.19% 1-Year +55.96%
3-Month +8.36% 3-Year +43.59%
Year To Date +20.17% 5-Year +35.49%
Expense Ratio 0.48

Top Fund Holdings for IBB

Filing Date: 05/22/2015
Name Position Value % of Total
Gilead Sciences Inc 6,644,144 742,217,326 8.301%
Amgen Inc 4,361,321 713,424,889 7.979%
Biogen Inc 1,679,413 669,548,375 7.488%
Celgene Corp 5,660,113 657,082,518 7.349%
Regeneron Pharmaceuticals Inc 1,266,236 650,693,356 7.277%
Mylan NV 6,371,778 443,858,055 4.964%
Illumina Inc 1,759,779 360,754,695 4.035%
Vertex Pharmaceuticals Inc 2,879,988 360,228,899 4.029%
Alexion Pharmaceuticals Inc 1,907,051 327,898,349 3.667%
BioMarin Pharmaceutical Inc 2,070,324 263,324,510 2.945%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil